Skip to content

Comparison of Pain Relief After Arthroscopic Knee Surgery: Adductor Canal Block and Genicular Nerve Block

Comparison of the Effectiveness of Adductor Canal Block and Genicular Nerve Block on Postoperative Pain and Analgesic Use in Arthroscopic Knee Surgeries

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06909851
Enrollment
68
Registered
2025-04-04
Start date
2025-03-10
Completion date
2025-09-30
Last updated
2025-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arthroscopic Knee Surgeries, Opioid Use, Pain Postoperative

Keywords

Genicular Nerve Block, Arthroscopic Knee Surgery, Adductor Canal Block, Postoperative Analgesia

Brief summary

This prospective randomized study aims to compare the analgesic efficacy of Adductor Canal Block (ACB) and Genicular Nerve Block (GNB) groups to relieve postoperative pain in participants between ages of 18-72 undergoing arthroscopic knee surgery under spinal anesthesia. The main question it aims to answer is: To demonstrate whether Adductor Canal Block or Genicular Nerve Block is more effective in postoperative analgesia in patients undergoing arthroscopic knee surgery based on pain scores, opioid consumption and patient satisfaction. Arthroscopic knee surgeries cause severe pain especially with movement in the post-operative period. After surgery, the movements of the participants are severely restricted because of pain, which increases the possibility of complications and postpones post-operative knee exercises. In this study, the participants' pain status, VAS score, opioid consumption and patient satisfaction will be measured with a simple scoring system for 24 hours at predetermined time points and then compared. Both types of blocks have pain-relieving effects. This study will only investigate which one is more effective in reducing pain, and there will be no deficiency in relieving the pain of the participants.

Interventions

Evaluation of postoperative analgesic effectiveness of ACB block in participants undergoing arthroscopic knee surgery under spinal anesthesia.

PROCEDUREGenicular Nerve Block (GNB)

Evaluation of postoperative analgesic effectiveness of GNB block in participants undergoing arthroscopic knee surgery under spinal anesthesia.

Sponsors

Başakşehir Çam & Sakura City Hospital
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Outcomes Assessor)

Intervention model description

Patients who are admitted to the orthopedic and traumatology clinic and are scheduled for arthroscopic knee surgery will be informed and monitored prior to the operation under spinal anesthesia. Preoperatively, either Adductor Canal Block (ACB) (Group A) or Genicular Nerve Block (GNB) (Group B) will be applied. Randomization will be performed using a computer-based method (http://www.randomizer.org) with a 1:1 allocation.

Eligibility

Sex/Gender
ALL
Age
18 Years to 72 Years
Healthy volunteers
Yes

Inclusion criteria

* Voluntary willingness to participate in the study. * Patients undergoing arthroscopic knee surgery (meniscus, ACL, arthroscopic intervention etc). * ASA I-II-III classification. * Aged between 18-72 years. * No contraindications for regional anesthesia, and deemed suitable for regional anesthesia by the anesthesiologist. * Undergoing surgery under spinal anesthesia. * Fully oriented and able to cooperate.

Exclusion criteria

* Undergoing surgery under general anesthesia. * Chronic analgesic use. * Presence of an active infection at the procedure site. * Outside the appropriate age range. * Inability to comply with postoperative pain/NRS follow-ups. * ASA IV-V classification. * Non-voluntary patients. * Pregnancy.

Design outcomes

Primary

MeasureTime frameDescription
Effectiveness on Pain Scores (NRS)Postoperative 24 hoursPostoperative pain assessment is performed using the Numerical Rating Scale (NRS). Participants are asked about their rest pain at Baseline 0, postoperative 1st, 2nd, 4th, 6th, 12th, and 24th hours after applying a preoperative peripheral nerve block. With this method, participants rate their pain with a precise numerical value from 0 to 10. While zero(0) represents no pain; Ten (10) represents the opposite end of the pain continuum (e.g., The most intense pain imaginable, As intense pain as possible, Maximum pain).

Secondary

MeasureTime frameDescription
Amount of rescue analgesia administrationPostoperative 24 hours.After the surgery all patients will be given 4 times a day Paracetamol 1 gram. Patients who still have pain (NRS 4 or higher) will be given Tramadol 1 mg/kg (maximum 400 mg Tramadol daily). Postoperative 24 hours the amount of the rescue analgesic (Tramadol) will be noted.
Postoperative Blood pressurePostoperative 24 hoursParticipants' blood pressure (mm/hg) will be monitored for 24 hours (Post op 1st, 2nd, 4th, 6th, 12th and 24th hours) postoperatively.
First Time Of Mobilisation/ExercisePostoperative 24 hoursFirst time of mobilisation/exercise will be noted.
Length of hospital stayPostoperative 14 daysLength of hospital stay will be noted.
Postoperative heart ratePostoperative 24 hoursParticipants' heart rate (bpm) will be monitored for 24 hours (Post op 1st, 2nd, 4th, 6th, 12th and 24th hours) postoperatively.
Postoperative oxygen saturation levelsPostoperative 24 hoursParticipants' oxygen saturation levels (spO2 %) will be monitored for 24 hours (Post op 1st, 2nd, 4th, 6th, 12th and 24th hours) postoperatively.
The Time of Rescue AnalgesicPostoperative 24 hoursAfter the surgery all patients will be given 4 times a day Paracetamol 1 gram. Patients who still have pain (NRS 4 or higher) will be given Tramadol 1 mg/kg (maximum 400 mg Tramadol daily). Postoperative 24 hours the time of the rescue analgesic usage (Tramadol) will be noted.

Countries

Turkey (Türkiye)

Contacts

Primary ContactMUZAFFER GENCER
dr.m.gencer07@gmail.com+905059436459
Backup ContactSİNAN ANAŞ
tharkunbalrogs@gmail.com+905314220762

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026